相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Emergency Postexposure Vaccination With Vesicular Stomatitis Virus-Vectored Ebola Vaccine After Needlestick
Lilin Lai et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Soluble Glycoprotein Is Not Required for Ebola Virus Virulence in Guinea Pigs
Thomas Hoenen et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Mutation rate and genotype variation of Ebola virus from Mali case sequences
T. Hoenen et al.
SCIENCE (2015)
Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak
Stephen K. Gire et al.
SCIENCE (2014)
Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates
Andrea Marzi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Management of Accidental Exposure to Ebola Virus in the Biosafety Level 4 Laboratory, Hamburg, Germany
Stephan Guenther et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Recombinant Vesicular Stomatitis Virus-Based Vaccines Against Ebola and Marburg Virus Infections
Thomas W. Geisbert et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Ebolavirus VP24 Binding to Karyopherins Is Required for Inhibition of Interferon Signaling
Mathieu Mateo et al.
JOURNAL OF VIROLOGY (2010)
Mucosal Immunization of Cynomolgus Macaques with the VSVΔG/ZEBOVGP Vaccine Stimulates Strong Ebola GP-Specific Immune Responses
Xiangguo Qiu et al.
PLOS ONE (2009)
Effective post-exposure treatment of Ebola infection
Heinz Feldmann et al.
PLOS PATHOGENS (2007)
Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs
Nancy J. Sullivan et al.
PLOS MEDICINE (2006)
Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses
SM Jones et al.
NATURE MEDICINE (2005)
Role of natural killer cells in innate protection against lethal Ebola virus infection
KL Warfield et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Development of a preventive vaccine for Ebola virus infection in primates
NJ Sullivan et al.
NATURE (2000)
The Ebola virus VP35 protein functions as a type IIFN antagonist
CF Basler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
